(Q44645584)

5 December 2017

title

Increased luteinizing hormone secretion in women with polycystic ovary syndrome is unaltered by prolonged insulin infusion (English)

1 reference

5 December 2017

Increased Luteinizing Hormone Secretion in Women with Polycystic Ovary Syndrome Is Unaltered by Prolonged Insulin Infusion (English)

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

polycystic ovary syndrome

29 March 2024

main subject

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

29 March 2024

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

29 March 2024

3

Michael H. Dahan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602789

29 March 2024

author name string

Ketan Patel

1

1 reference

5 December 2017

Mickey S. Coffler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602789

29 March 2024

Richard Y. Yoo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602789

29 March 2024

Mark A. Lawson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602789

29 March 2024

Pamela J. Malcom

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602789

29 March 2024

R. Jeffrey Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602789

29 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

5 December 2017

published in

The Journal of Clinical Endocrinology and Metabolism

1 reference

5 December 2017

volume

88

1 reference

5 December 2017

issue

11

1 reference

5 December 2017

page(s)

5456-5461

1 reference

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

The polycystic ovary syndrome

29 March 2024

2

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells

29 March 2024

3

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro.

29 March 2024

4

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Modulation of anterior pituitary luteinizing hormone response to gonadotropin-releasing hormone by insulin-like growth factor I in vitro

29 March 2024

5

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans

29 March 2024

6

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

29 March 2024

8

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.

29 March 2024

10

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

29 March 2024

11

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

29 March 2024

12

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

29 March 2024

14

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

29 March 2024

15

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women.

29 March 2024

17

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

29 March 2024

19

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women

29 March 2024

20

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

29 March 2024

21

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

29 March 2024

26

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Interactions of insulin-like growth factor-I, insulin and estradiol with GnRH-stimulated luteinizing hormone release from female rat gonadotrophs

29 March 2024

30

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

Hyperinsulinemia and hyperandrogenemia: in vivo androgen response to insulin infusion.

29 March 2024

31

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030816

29 March 2024

Identifiers

1 reference

5 December 2017

1 reference